Cytospire Therapeutics
UKEntry
2026
Hold
New
Status
Active
Who owns Cytospire Therapeutics?
Cytospire Therapeutics is currently owned by 4Bio Partners through 4BIO Ventures III (2022 vintage), since 2026. Across its history, Cytospire Therapeutics has been through 3 private equity ownership periods, detailed in the timeline below.
Hand-verified · updated 2026-05-21
Most recent investor
4Bio Partners4BIO Ventures III · 2022 · Life Sciences VC
3 ownership periods · full history below
Key facts
Ownership history
3 ownership periods
Active
LifeArcActive
2023 · present(3yr) · LifeArc Ventures · 1992 · Life Sciences VC
AbingworthActive
2026 · present(<1yr) · Abingworth Bioventures 8 · 2021 · Life Sciences VC
4Bio PartnersActive
2026 · present(<1yr) · 4BIO Ventures III · 2022 · Life Sciences VC
More from 4BIO Ventures III
Other portfolio companies in the same fund.
Switzerland
US
More PE-backed in Biotech
Comparable biotech deals from other GPs.
Track Cytospire Therapeutics
Save this record to your watchlist and pick up your research where you left off. No spam.
Who could buy Cytospire Therapeutics?
4 strategic and 116financial buyers match this company's sector and geography profile, ranked from verified European deal history.
Find likely buyersGet the full record on Cytospire Therapeutics.
Free. No credit card. 30 seconds. Exit buyers and MOIC on Pro.
Hand-checked deal notes on this investment
Save this company to your watchlist
Exit buyers and MOIC on realized deals (Pro)
Already a member? Sign in
Look up another firm or company
Data refreshed weekly · Sourced from public filings · Report an issue